| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-067037 |
| cik | 1681087 |
| name | TECTONIC THERAPEUTIC, INC. |
| sic | 2836 |
| countryba | US |
| stprba | MA |
| cityba | WATERTOWN |
| zipba | 02472 |
| bas1 | 490 ARSENAL WAY |
| bas2 | SUITE 210 |
| baph | (339) 666-3320 |
| countryma | US |
| stprma | MA |
| cityma | WATERTOWN |
| zipma | 02472 |
| mas1 | 490 ARSENAL WAY |
| mas2 | SUITE 210 |
| countryinc | US |
| stprinc | DE |
| ein | 810710585 |
| former | AVROBIO, INC. |
| changed | 20180131 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 16:21:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | tecx-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-067037 | 20250331 | Accounts Payable Current | 6254000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 9000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Adjusted Balance Beginning Of Period Share | 1407753.0000 | shares | 1 | 0000950170-25-067037 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20240331 | Adjusted Balance Beginning Of Period Value | -84636000.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20241231 | Cash And Cash Equivalents At Carrying Value | 141239000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Common Stock Shares Issued | 1470839.0000 | shares | 0 | us-gaap/2024 | Financial Instrument= Simple Agreements For Future Equity; Type Of Common Stock= Avrobio; | ||
| 0000950170-25-067037 | 20240331 | Foreign Currency Transaction And Translation Adjustment Net Of Tax Other Comprehensive Income Loss | -42000.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20240331 | Increase Decrease In Accounts Payable | 1510000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -2221000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Interest Expense Nonoperating | 31000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Liabilities | 13793000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Net Income Loss | -15221000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-067037 | 20240331 | Operating Expenses | 12968000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Operating Lease Liability Current | 1874000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Operating Lease Liability Noncurrent | 132000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Operating Lease Right Of Use Asset | 2235000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Prepaid Expense And Other Assets Current | 5618000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Private Placement Costs Included In Accrued Expenses And Other Current Liabilities | 0.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20240331 | Profit Loss | -15221000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Profit Loss | -15906000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Research And Development Expense | 100000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Harvard Agreement; | ||
| 0000950170-25-067037 | 20231231 | Stockholders Equity | 5979000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 17157661.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Accrued Liabilities Current | 4907000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Adjusted Balance Beginning Of Period Value | -11000.0000 | USD | 1 | 0000950170-25-067037 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-067037 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 321000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Change In Fair Value Of Safe Liabilities | 0.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-067037 | 20241231 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20250331 | Common Stock Shares Outstanding | 18671229.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Earnings Per Share Basic | -0.9300 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Earnings Per Share Diluted | -10.9700 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Finance Lease Principal Payments | 118000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Foreign Currency Transaction And Translation Adjustment Net Of Tax Other Comprehensive Income Loss | -7000.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20250331 | Increase Decrease In Operating Lease Liability | -553000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Net Cash Provided By Used In Investing Activities | -4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Net Income Loss | 15221000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-067037 | 20250331 | Net Income Loss | 15906000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-067037 | 20240331 | Other Nonoperating Income Expense | -403000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Payments To Acquire Property Plant And Equipment | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Payments To Acquire Property Plant And Equipment | 27000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Property Plant And Equipment Net | 2151000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Research And Development Expense | 100000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Harvard Agreement; | ||
| 0000950170-25-067037 | 20250331 | Restricted Cash | 587000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20231231 | Shares Outstanding | 6825483.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20240331 | Stockholders Equity | -53000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-067037 | 20240331 | Stockholders Equity | 6304000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20241231 | Stockholders Equity | -148586000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-067037 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20250331 | Stockholders Equity | 465524000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20240131 | Stock Issued During Period Shares New Issues | 7790889.0000 | shares | 0 | us-gaap/2024 | Agreement= Subscription Agreement; | ||
| 0000950170-25-067037 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 321000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2103000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Common Stock Par Or Stated Value Per Share | 12.4000 | USD | 0 | us-gaap/2024 | Financial Instrument= Simple Agreements For Future Equity; | ||
| 0000950170-25-067037 | 20240331 | Depreciation Depletion And Amortization | 377000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Finance Lease Liability Noncurrent | 283000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Finance Lease Right Of Use Asset | 813000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | General And Administrative Expense | 2150000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Liabilities And Stockholders Equity | 314829000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Liabilities Current | 13510000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Net Cash Provided By Used In Investing Activities | -27000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Net Cash Provided By Used In Operating Activities | -9273000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Net Income Loss | -15906000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-067037 | 20250331 | Nonoperating Income Expense | 2392000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Other Assets Noncurrent | 156000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Proceeds From Issuance Of Private Placement | 177268000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Research And Development Expense | 13036000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Retained Earnings Accumulated Deficit | -164492000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Shares Outstanding | 18671229.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Value New Issues | 173098000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-067037 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 1387303.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Assets | 152905000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Assets | 314829000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Cash And Cash Equivalents At Carrying Value | 18748000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -10021000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Common Stock Par Or Stated Value Per Share | 12.4000 | USD | 0 | us-gaap/2024 | Financial Instrument= Simple Agreements For Future Equity; Type Of Common Stock= Avrobio; | ||
| 0000950170-25-067037 | 20241231 | Common Stock Shares Issued | 14856309.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Common Stock Shares Issued | 18671229.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Deferred Offering Costs Included In Accrued Expenses And Other Current Liabilities | 0.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Finance Lease Liability Noncurrent | 387000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Foreign Currency Transaction And Translation Adjustment Net Of Tax Other Comprehensive Income Loss | -42000.0000 | USD | 1 | 0000950170-25-067037 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-067037 | 20250331 | General And Administrative Expense | 5262000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Interest Expense Nonoperating | 20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Liabilities Current | 11610000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Net Income Loss | -15221000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Nonoperating Income Expense | -2253000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Operating Lease Right Of Use Asset | 1724000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 511000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Other Comprehensive Income Loss Tax | 15271000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Private Placement Costs Included In Accrued Expenses And Other Current Liabilities | 4170000.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20240331 | Proceeds From Issuance Of Private Placement | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Proceeds From Stock Options Exercised | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Property Plant And Equipment Net | 1924000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Research And Development Expense | 10818000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Restricted Cash Noncurrent | 587000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Share Based Compensation | 2103000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20231231 | Stockholders Equity | -84636000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Stockholders Equity | 301036000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Stock Issued During Period Shares Reverse Stock Splits | 3177808.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 1535.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 64866.0000 | shares | 1 | us-gaap/2024 | Plan Name= Two Thousand Nineteen And Two Thousand Twenty Four; | ||
| 0000950170-25-067037 | 20240331 | Increase Decrease In Operating Lease Liability | -324000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Increase Decrease In Other Noncurrent Assets | -14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Net Cash Provided By Used In Financing Activities | 178122000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Other Comprehensive Income Loss Tax | 15913000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Accounts Payable Current | 976000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Additional Paid In Capital | 289351000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Assets Current | 146857000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 141826000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Depreciation Depletion And Amortization | 360000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Finance Lease Liability Current | 475000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Finance Lease Right Of Use Asset | 919000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -3417000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Payment Of Deferred Offering Costs | -554000.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20250331 | Proceeds From Stock Options Exercised | 972000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Share Based Compensation | 321000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20231231 | Shares Outstanding | 2634246.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20240331 | Shares Outstanding | 1409288.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20250331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20241231 | Stockholders Equity | 140776000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Stockholders Equity | 9000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Shares New Issues | 3689465.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 60589.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 4000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 972000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 17157661.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2103000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-067037 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20250331 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Common Stock Shares Issued | 2752216.0000 | shares | 0 | us-gaap/2024 | Financial Instrument= Simple Agreements For Future Equity; | ||
| 0000950170-25-067037 | 20250331 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -76000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Finance Lease Principal Payments | 118000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Increase Decrease In Other Noncurrent Assets | -24000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Investment Income Interest | 2444000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Liabilities And Stockholders Equity | 152905000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Net Cash Provided By Used In Financing Activities | -668000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Net Income Loss | -15906000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Operating Income Loss | -12968000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Operating Income Loss | -18298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Operating Lease Liability Current | 2295000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -50000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Other Nonoperating Income Expense | -32000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Research And Development Expense | 100000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= License Agreement; | ||
| 0000950170-25-067037 | 20240331 | Restricted Cash | 587000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Restricted Cash Noncurrent | 587000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Retained Earnings Accumulated Deficit | -148586000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Shares Outstanding | 3647675.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20231231 | Stockholders Equity | 80627000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20240331 | Stock Issued During Period Shares Reverse Stock Splits | 1226493.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20240331 | Adjusted Balance Beginning Of Period Value | 80627000.0000 | USD | 1 | 0000950170-25-067037 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20250331 | Assets Current | 309643000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 29356000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 19335000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 165007000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Change In Fair Value Of Safe Liabilities | -2075000.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Earnings Per Share Diluted | -0.9300 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Finance Lease Liability Current | 489000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Increase Decrease In Accounts Payable | 1584000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 1382000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Operating Lease Liability Noncurrent | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Other Assets Noncurrent | 138000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Payment Of Deferred Offering Costs | 0.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Prepaid Expense And Other Assets Current | 3397000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Stockholders Equity | -99574000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Stockholders Equity | 80627000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20240331 | Stockholders Equity | -105825000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-067037 | 20241231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Value New Issues | 173098000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-067037 | 20250331 | Stockholders Equity | -164492000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 125455.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20241231 | Accrued Liabilities Current | 7850000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Additional Paid In Capital | 465524000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Adjusted Balance Beginning Of Period Share | 3647675.0000 | shares | 1 | 0000950170-25-067037 | Class Of Stock= Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-067037 | 20240331 | Adjusted Balance Beginning Of Period Value | 5979000.0000 | USD | 1 | 0000950170-25-067037 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20240331 | Adjusted Balance Beginning Of Period Value | -90604000.0000 | USD | 1 | 0000950170-25-067037 | Equity Components= Retained Earnings; | ||
| 0000950170-25-067037 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 11928000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-067037 | 20250331 | Cash And Cash Equivalents At Carrying Value | 306246000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 306833000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Common Stock Shares Outstanding | 14856309.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Deferred Offering Costs Included In Accrued Expenses And Other Current Liabilities | 1576000.0000 | USD | 1 | 0000950170-25-067037 | |||
| 0000950170-25-067037 | 20240331 | Earnings Per Share Basic | -10.9700 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Foreign Currency Transaction And Translation Adjustment Net Of Tax Other Comprehensive Income Loss | -7000.0000 | USD | 1 | 0000950170-25-067037 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-067037 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -289000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Investment Income Interest | 256000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Liabilities | 12129000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Net Cash Provided By Used In Operating Activities | -13083000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Operating Expenses | 18298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 294000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-067037 | 20240331 | Research And Development Expense | 100000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= License Agreement; | ||
| 0000950170-25-067037 | 20241231 | Shares Outstanding | 14856309.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20231231 | Stockholders Equity | -11000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-067037 | 20231231 | Stockholders Equity | -90604000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-067037 | 20241231 | Stockholders Equity | 289351000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20250331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-067037 | 20250331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-067037 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 972000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-067037 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 1387303.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Proceeds From Issuance Of Private Placement | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Finance Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Finance Lease Principal Payments | us-gaap/2024 | 0 | 0 | monetary | D | C | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Stock Issued During Period Shares Reverse Stock Splits | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Reverse Stock Splits | Reduction in the number of shares during the period as a result of a reverse stock split. | |
| Private Placement Costs Included In Accrued Expenses And Other Current Liabilities | 0000950170-25-067037 | 1 | 0 | monetary | D | C | Private Placement Costs Included in Accrued Expenses and Other Current Liabilities | Private Placement Costs Included in Accrued Expenses and Other Current Liabilities |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Adjusted Balance Beginning Of Period Value | 0000950170-25-067037 | 1 | 0 | monetary | D | D | Adjusted Balance Beginning Of Period Value | Adjusted balance beginning of period value. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Deferred Offering Costs Included In Accrued Expenses And Other Current Liabilities | 0000950170-25-067037 | 1 | 0 | monetary | D | C | Deferred Offering Costs Included in Accrued Expenses and Other Current Liabilities | Deferred Offering Costs Included in Accrued Expenses and Other Current Liabilities |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Finance Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | Amount, after accumulated amortization, of right-of-use asset from finance lease. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Restricted Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash | Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Change In Fair Value Of Safe Liabilities | 0000950170-25-067037 | 1 | 0 | monetary | D | C | Change In Fair Value Of SAFE Liabilities | Change in fair value of SAFE liabilities. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Finance Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from finance lease, classified as current. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Comprehensive Income Loss Tax | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Comprehensive Income (Loss), Tax | Amount of tax expense (benefit) allocated to other comprehensive income (loss). |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Adjusted Balance Beginning Of Period Share | 0000950170-25-067037 | 1 | 0 | shares | D | Adjusted Balance Beginning Of Period Share | Adjusted balance beginning of period share. | |
| Payment Of Deferred Offering Costs | 0000950170-25-067037 | 1 | 0 | monetary | D | D | Payment of Deferred Offering Costs | Payment of Deferred Offering Costs |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Foreign Currency Transaction And Translation Adjustment Net Of Tax Other Comprehensive Income Loss | 0000950170-25-067037 | 1 | 0 | monetary | D | C | Foreign Currency Transaction And Translation Adjustment Net Of Tax Other Comprehensive Income Loss | Foreign currency transaction and translation adjustment net of tax other comprehensive income loss. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-067037 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred Stock, Shares Outstanding | 0 |
| 0000950170-25-067037 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-067037 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-067037 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-067037 | 2 | 6 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-067037 | 2 | 7 | BS | 0 | H | Finance Lease Right Of Use Asset | us-gaap/2024 | Finance right-of-use assets, net | 0 |
| 0000950170-25-067037 | 2 | 8 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating right-of-use assets | 0 |
| 0000950170-25-067037 | 2 | 9 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-067037 | 2 | 10 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-067037 | 2 | 11 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-067037 | 2 | 14 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-067037 | 2 | 15 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-067037 | 2 | 16 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability | 0 |
| 0000950170-25-067037 | 2 | 17 | BS | 0 | H | Finance Lease Liability Current | us-gaap/2024 | Finance lease liability | 0 |
| 0000950170-25-067037 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-067037 | 2 | 19 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, non-current | 0 |
| 0000950170-25-067037 | 2 | 20 | BS | 0 | H | Finance Lease Liability Noncurrent | us-gaap/2024 | Finance lease liability, non-current | 0 |
| 0000950170-25-067037 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-067037 | 2 | 22 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 11) | 0 |
| 0000950170-25-067037 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, 10,000,000 shares and no shares authorized as of March 31, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
| 0000950170-25-067037 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 18,671,229 and 14,856,309 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0000950170-25-067037 | 2 | 26 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-067037 | 2 | 27 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
| 0000950170-25-067037 | 2 | 28 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-067037 | 2 | 29 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-067037 | 2 | 30 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-067037 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred Stock, Shares Authorized | 0 |
| 0000950170-25-067037 | 3 | 7 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred Stock, Shares Issued | 0 |
| 0000950170-25-067037 | 3 | 9 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-067037 | 3 | 10 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, authorized | 0 |
| 0000950170-25-067037 | 3 | 11 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, issued | 0 |
| 0000950170-25-067037 | 3 | 12 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, outstanding | 0 |
| 0000950170-25-067037 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-067037 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-067037 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-067037 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0000950170-25-067037 | 4 | 7 | IS | 0 | H | Change In Fair Value Of Safe Liabilities | 0000950170-25-067037 | Change in fair value of SAFE liabilities | 0 |
| 0000950170-25-067037 | 4 | 8 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
| 0000950170-25-067037 | 4 | 9 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0000950170-25-067037 | 4 | 10 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other expense | 0 |
| 0000950170-25-067037 | 4 | 11 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income (expense), net | 0 |
| 0000950170-25-067037 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-067037 | 4 | 13 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share attributable to common stockholders, basic | 0 |
| 0000950170-25-067037 | 4 | 14 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share attributable to common stockholders, diluted | 0 |
| 0000950170-25-067037 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average common shares outstanding, basic | 0 |
| 0000950170-25-067037 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average common shares outstanding, diluted | 0 |
| 0000950170-25-067037 | 4 | 18 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation adjustment | 0 |
| 0000950170-25-067037 | 4 | 19 | IS | 0 | H | Other Comprehensive Income Loss Tax | us-gaap/2024 | Comprehensive loss | 1 |
| 0000950170-25-067037 | 5 | 16 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0000950170-25-067037 | 5 | 17 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0000950170-25-067037 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Reverse Stock Splits | us-gaap/2024 | Retroactive application of reverse recapitalization | 1 |
| 0000950170-25-067037 | 5 | 19 | EQ | 0 | H | Adjusted Balance Beginning Of Period Value | 0000950170-25-067037 | Adjusted balance, beginning of period | 0 |
| 0000950170-25-067037 | 5 | 20 | EQ | 0 | H | Adjusted Balance Beginning Of Period Share | 0000950170-25-067037 | Adjusted balance, beginning of period (in shares) | 0 |
| 0000950170-25-067037 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
| 0000950170-25-067037 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options (in shares) | 0 |
| 0000950170-25-067037 | 5 | 23 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-067037 | 5 | 24 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock in connection with the private placement, net of offering costs of $11,928 (in Shares) | 0 |
| 0000950170-25-067037 | 5 | 25 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock in connection with the private placement, net of offering costs of $11,928 | 0 |
| 0000950170-25-067037 | 5 | 26 | EQ | 0 | H | Foreign Currency Transaction And Translation Adjustment Net Of Tax Other Comprehensive Income Loss | 0000950170-25-067037 | Foreign currency translation adjustment | 0 |
| 0000950170-25-067037 | 5 | 27 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0000950170-25-067037 | 5 | 28 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0000950170-25-067037 | 5 | 29 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0000950170-25-067037 | 6 | 6 | EQ | 1 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | Net of offering costs | 0 |
| 0000950170-25-067037 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-067037 | 7 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization expense | 0 |
| 0000950170-25-067037 | 7 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-067037 | 7 | 6 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Reduction in the carrying amount of the operating right-of-use assets | 0 |
| 0000950170-25-067037 | 7 | 7 | CF | 0 | H | Change In Fair Value Of Safe Liabilities | 0000950170-25-067037 | Change in fair value of SAFE liabilities | 1 |
| 0000950170-25-067037 | 7 | 9 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0000950170-25-067037 | 7 | 10 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other non-current assets | 1 |
| 0000950170-25-067037 | 7 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-067037 | 7 | 12 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-067037 | 7 | 13 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
| 0000950170-25-067037 | 7 | 14 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-067037 | 7 | 16 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property, equipment and improvements | 1 |
| 0000950170-25-067037 | 7 | 17 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0000950170-25-067037 | 7 | 19 | CF | 0 | H | Payment Of Deferred Offering Costs | 0000950170-25-067037 | Payment of deferred offering costs | 0 |
| 0000950170-25-067037 | 7 | 20 | CF | 0 | H | Proceeds From Issuance Of Private Placement | us-gaap/2024 | Proceeds from the private placement, net of offering costs | 0 |
| 0000950170-25-067037 | 7 | 21 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from the exercise of stock options | 0 |
| 0000950170-25-067037 | 7 | 22 | CF | 0 | H | Finance Lease Principal Payments | us-gaap/2024 | Repayment of finance lease obligations | 1 |
| 0000950170-25-067037 | 7 | 23 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities | 0 |
| 0000950170-25-067037 | 7 | 24 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect of exchange rate changes on cash and cash equivalents | 0 |
| 0000950170-25-067037 | 7 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash and cash equivalents and restricted cash | 0 |
| 0000950170-25-067037 | 7 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents and restricted cash as of beginning of period | 0 |
| 0000950170-25-067037 | 7 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents and restricted cash as of end of period | 0 |
| 0000950170-25-067037 | 7 | 29 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-067037 | 7 | 30 | CF | 0 | H | Restricted Cash | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-067037 | 7 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Total cash, cash equivalents and restricted cash | 0 |
| 0000950170-25-067037 | 7 | 33 | CF | 0 | H | Deferred Offering Costs Included In Accrued Expenses And Other Current Liabilities | 0000950170-25-067037 | Deferred offering costs included in accrued expenses and other current liabilities | 0 |
| 0000950170-25-067037 | 7 | 34 | CF | 0 | H | Private Placement Costs Included In Accrued Expenses And Other Current Liabilities | 0000950170-25-067037 | Private Placement Costs Included in Accrued Expenses and Other Current Liabilities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |